Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California Davis
Davis, California, United States
- University of California Los Angeles
Los Angeles, California, United States
- University of Colorado Denver
Denver, Colorado, United States
- University of Miami Miller School of Medicine
Miami, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University
Evanston, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University School of Medicine in St Louis
St Louis, Missouri, United States
- University at Buffalo, the State University of New York
Buffalo, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Cornell Medical College
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- University at Stony Brook, the State University of New York
Stony Brook, New York, United States
- University at Upstate, the State University of New York
Syracuse, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- University of Cincinnati, Department of Neurology
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Virginia Charlottesville
Charlottesville, Virginia, United States
- Swedish Medical Center - Seattle
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2013
- Primary completion
- 31 May 2017
- Completion
- 31 Dec 2017
- Last update posted
- 28 Jul 2020
- Registered enrollment
- 255
- Registry id
- NCT01982942
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.